The Venture Codex

Participated · Series D · Jul 2016

GC Aesthetics develops, manufactures and commercializes implant products, principally silicone breast implants. The company is the parent of Nagor (UK) and Eurosilicone (France) and operates manufacturing facilities in the United Kingdom and France. It reports more than 325,000 implants manufactured with medical‑grade silicone supplied from ISO 9001‑certified sources, and its products are marketed in over 75 countries. GC Aesthetics employs around 400 people globally and is led by CEO Ayse Kocak. The company completed a $20m Series D financing and intends to use the funds to expand commercial operations, launch its sixth‑generation product IMPLEO globally, invest in product innovation, and further improve customer service. GC Aesthetics manufactures and sells breast implants and operates two brands, Nagor and Eurosilicone. Founded in 2007 and led by CEO Ayse Kocak, the company offers a wide product range with nearly 600 implant types. It sells its products in 90 countries and manufactures at its own facilities in Scotland, England and France. The company raised $40m in financing to support its plans. GC Aesthetics intends to use the funds for international expansion as well as new product development and launches. GC Aesthetics designs, manufactures and distributes medical devices for the global aesthetics market. The company already supplies customers in 90 countries across Europe, Asia and South America. It is based in Dublin, Ireland. Management says the funds will be used to accelerate the company’s expansion plans and expand the global reach of its products. GC Aesthetics received a US$30m private equity investment from Montreux Equity Partners. CEO Ken Pearce commented that the investment allows the company to expand its global reach in this rapidly growing sector.